Newsletter

CMIT published a periodic online newsletter highlighting new and exciting studies, research initiatives, and events to help connect the microbiome research community.

Subscribe here

September 2019

Leave “Parachute Science” Behind When Jumping Into Global Microbiome Research

BY REPRESENTATIVES OF THE GLOBAL MICROBIOME CONSERVANCY

Awareness is growing, but still today researchers from high-income countries sometimes conduct research that relies on analyzing samples collected in low-income countries without affording any benefit to local scientists or community. This practice of “dropping in” on another country to take whatever is needed to further research, termed “parachute science”, can apply to any scientific field.

Read the September 2019 issue

July 2019

Moving Microbiome Research from the Bench to the Bedside: Challenges and Opportunities

BY ASHWIN N. ANANTHAKRISHNAN, MD, MPH

Nearly every month, we see studies linking alterations in the composition of the gut microbiome, crudely termed “dysbiosis”, with one disease or the other. The spectrum of diseases linked to such alterations range from inflammatory bowel diseases (IBD) to autism to obesity to depression…

Read the July 2019 issue

June 2019

We should share the data generated during clinical research, not just the key findings.

BY ERIC ALM

Participating in a clinical trial is a big step. Patients understand that new therapeutics can’t be developed without trials, but there’s no guarantee that the intervention being tested will be effective, safe, or even available when the trial is over…

Read the June 2019 issue

November 2018

Diversity matters… but maybe not in our guts

BY ERIC ALM

We seem to have collectively agreed that ‘more is better’ when it comes to microbiome diversity. However, there’s not much evidence that within the “normal” spectrum of microbiome diversity — i.e. what’s observed in healthy individuals — that having more diversity is better for you…

Read the November 2018 issue

Get Involved

Get Involved!

To develop the spectrum of different therapies needed for patients with microbiome-associated disease, CMIT needs to continue to attract the best minds to join our community.